Sign In
Buy ASC
$15.97
-0.220 (-1.36%)
At Close: Jun 03, 2026
- Using Asclet i s' proprietary U ltra- L ong- A cting P latform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-mon
Ardmore Shipping Corporation (ASC) Q3 2025 Earnings Call Transcript
11:51am, Wednesday, 05'th Nov 2025
Ardmore Shipping Corporation ( ASC ) Q3 2025 Earnings Call November 5, 2025 10:00 AM EST Company Participants Gernot Ruppelt - CEO & Director Bart Kelleher - President & Director Conference Call Parti
Ardmore Shipping Corporation Announces Financial Results For The Three and Nine Months Ended September 30, 2025
08:00am, Wednesday, 05'th Nov 2025
HAMILTON, Bermuda , Nov. 5, 2025 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore", the "Company" or "we") today announced results for the three and nine months ended September 30, 2
-Positive data from Phase Ib study of ASC30 oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction; safe and well tolerated with only mild-to-moderate gastrointestinal (GI) ad
Ardmore Shipping (ASC) Expected to Announce Quarterly Earnings on Wednesday
02:45am, Tuesday, 04'th Nov 2025
Ardmore Shipping (NYSE: ASC - Get Free Report) is anticipated to issue its Q3 2025 results before the market opens on Wednesday, November 5th. Analysts expect the company to announce earnings of $0.28
Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development
08:10pm, Wednesday, 29'th Oct 2025
-In head-to-head non-human primate (NHP) studies, average observed half-life of ASC36 was approximately 15 days, 3 -fold longer than petrelintide, which supports once-monthly subcutaneous (SQ) dosing
DOWNERS GROVE, Ill.--(BUSINESS WIRE)--Duly Health and Care, through its Chicagoland medical group, DuPage Medical Group, Ltd., has announced the acquisition of a minority ownership interest in Valley
Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025
06:00am, Monday, 27'th Oct 2025
-Multiple posters being presented on Ascletis' small molecule and peptide obesity programs -Full analysis of 28-day multiple ascending dose study of oral GLP-1R small molecule agonist ASC30 as a late-
Ardmore Shipping Announces Third Quarter 2025 Conference Call and Webcast
04:15pm, Wednesday, 22'nd Oct 2025
HAMILTON, Bermuda , Oct. 22, 2025 /PRNewswire/ -- Ardmore Shipping Corporation (NYSE: ASC) ("Ardmore" or the "Company") today announced that the Company plans to announce its third quarter earnings be
Ardmore Shipping: A Compelling Buy At 0.66x NAV With Rising MR Rates (Upgrade)
09:15am, Tuesday, 21'st Oct 2025
Ardmore Shipping Corporation maintains a strong balance sheet, low leverage, and recently acquired three MR tankers. Despite a conservative dividend policy, ASC's valuation at 0.66x NAV offers over 30
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration
06:00am, Tuesday, 14'th Oct 2025
- Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a Phase III ra
Ardmore Shipping (ASC) Stock Sinks As Market Gains: Here's Why
06:51pm, Monday, 06'th Oct 2025
Ardmore Shipping (ASC) concluded the recent trading session at $11.7, signifying a -3.15% move from its prior day's close.
Is Ardmore Shipping (ASC) a Buy as Wall Street Analysts Look Optimistic?
10:30am, Wednesday, 01'st Oct 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Ardmore Shipping Corporation (ASC) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 01'st Oct 2025
Ardmore Shipping (ASC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
TKCM is Entering the 700 Billion Dollar Affordable Housing Market
09:00am, Tuesday, 30'th Sep 2025
ASC Global Inc. is offering new solution to the affordable housing crisis in the U.S. BRADENTON, FL / ACCESS Newswire / September 30, 2025 / ASC Global Inc. is a wholly-owned subsidiary of Token Commu
